Join the Rosacea group to help and get support from people like you.
Rosacea News
Related terms: Acne rosacea
Isotretinoin Effective for Acne in Those Receiving Gender-Affirming Therapy
FRIDAY, June 7, 2024 – Isotretinoin is well tolerated and effective for individuals receiving masculinizing gender-affirming hormonal therapy who have acne, according to a study published online May...
Could a Low-Cal Keto Diet Help Ease Acne?
WEDNESDAY, May 15, 2024 – In a small pilot study, some young women looking to lose weight on a low-calorie keto diet got an unexpected benefit: Their acne began to clear up. “These findings r...
Erenumab Effective, Safe for Rosacea-Linked Erythema, Flushing
WEDNESDAY, April 17, 2024 – The anticalcitonin gene-related peptide-receptor monoclonal antibody erenumab is effective and safe for treatment of rosacea-associated erythema and flushing, according...
Tips To Getting Your Rosacea Under Control
FRIDAY, April 12, 2024 – Rosacea is a common skin condition that causes redness on a person’s face. It commonly appears as a tendency to blush or flush more easily, but also can cause more serious s...
FDA Approves Epsolay (benzoyl peroxide) Cream for the Treatment of Rosacea
NESS ZIONA, Israel and ZUG, Switzerland, April 25, 2022 (GLOBE NEWSWIRE) – Sol-Gel Technologies, Ltd. (NASDAQ: SLGL), a dermatology company focused on identifying, developing and commercializing...
Allergan Announces FDA Approval of Rhofade (oxymetazoline hydrochloride) Cream for Facial Erythema Associated with Rosacea
DUBLIN, Jan. 19, 2017 /PRNewswire/ – Allergan plc, (NYSE: AGN), a leading global pharmaceutical company, announced today the approval of Rhofade cream by the U.S. Food and Drug Administration (FDA)...
FDA Approves Finacea (azelaic acid) Foam for Rosacea
WHIPPANY, N.J., July 31, 2015 /PRNewswire/ – Bayer HealthCare today announced that the U.S. Food and Drug Administration (FDA) has approved Finacea (azelaic acid) Foam, 15% for the topical treatment...
Galderma Receives FDA Approval of Soolantra (ivermectin) Cream for Rosacea
FORT WORTH, Texas, December 23, 2014 --(BUSINESS WIRE)--Galderma Laboratories, L.P. today announced that the U.S. Food and Drug Administration (FDA) approved Soolantra (ivermectin) Cream, 1% for the...
Galderma Receives FDA Approval of Mirvaso for the Topical Treatment of Facial Erythema of Rosacea
FT. WORTH, Texas – August 26, 2013 – Galderma Laboratories, L.P. today announced that the U.S. Food and Drug Administration (FDA) has approved Mirvaso (brimonidine) topical gel, 0.33%* for the top...
Ask a question
To post your own question to this support group, sign in or create an account.